 | Soligenix (NASDAQ:SNGX) Stock Price Down 10%
americanbankingnews.com - March 5 at 8:36 PM |
 | Looking For The Best Penny Stocks To Watch? 3 To Know Right Now - StreetInsider.com
streetinsider.com - March 4 at 5:51 PM |
 | The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company - Benzinga
benzinga.com - March 4 at 12:51 PM |
| Soligenix (NASDAQ:SNGX) Shares Gap Up to $1.61
americanbankingnews.com - March 4 at 11:40 AM |
 | Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine - Yahoo Finance
finance.yahoo.com - March 4 at 7:51 AM |
| Soligenix Announces Positive Progress in the Pre-clinical Development of its COVID-19 Vaccine
finance.yahoo.com - March 4 at 7:51 AM |
| Soligenix Shares Rally On Positive Preclinical Data For COVID-19 Vaccine Candidate
benzinga.com - March 4 at 7:28 AM |
| Soligenix (NASDAQ:SNGX) Trading Down 7.7%
americanbankingnews.com - February 25 at 9:40 PM |
| SOLIGENIX, INC. (SNGX) - Soligenix Issues Shareholder Letter, Highlights Upcoming Catalysts - Benzinga
benzinga.com - February 25 at 3:24 AM |
| Soligenix (NASDAQ:SNGX) Trading 5.2% Higher
americanbankingnews.com - February 24 at 10:38 PM |
|
| Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter - Yahoo Finance
finance.yahoo.com - February 24 at 7:21 AM |
| Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter
finance.yahoo.com - February 24 at 7:21 AM |
| Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track - Yahoo Finance
finance.yahoo.com - February 23 at 11:19 AM |
| Soligenix is Ready for Commercialization of SGX301 (HyBryte(TM)); FDA Has Approval Process on Fast Track
finance.yahoo.com - February 23 at 11:19 AM |
| Soligenix (NASDAQ:SNGX) Trading Down 8.9%
americanbankingnews.com - February 17 at 8:36 PM |
| Soligenix (NASDAQ:SNGX) Shares Gap Up to $2.14
americanbankingnews.com - February 16 at 3:02 PM |
 | Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference - PRNewswire
prnewswire.com - February 12 at 12:05 AM |
| Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference - Yahoo Finance
finance.yahoo.com - February 11 at 2:05 PM |
| Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference
finance.yahoo.com - February 11 at 9:04 AM |
| Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301 - Yahoo Finance
finance.yahoo.com - February 9 at 9:27 AM |
| Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301
finance.yahoo.com - February 9 at 9:27 AM |
 | Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma - MarketWatch
marketwatch.com - February 2 at 9:17 AM |
| Soligenix, Inc. (SNGX) Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma - StreetInsider.com
streetinsider.com - February 1 at 6:52 PM |
| Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma
finance.yahoo.com - February 1 at 8:52 AM |
| SNGX: Provides Update on SGX301 Commercialization Plan…
finance.yahoo.com - January 28 at 1:23 PM |
| Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - Yahoo Finance
finance.yahoo.com - January 25 at 12:43 PM |
| Soligenix Poised to Announce US Commercialization Plans of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma
finance.yahoo.com - January 25 at 12:43 PM |
| Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - MarketWatch
marketwatch.com - January 21 at 10:17 PM |
|
| Soligenix Announces Investor Webcast Event: U.S. Commercialization of SGX301 in the Treatment of Cutaneous T-Cell Lymphoma - Yahoo Finance
finance.yahoo.com - January 19 at 6:11 PM |
 | Soligenix inks supply and distribution deal for SGX301 companion light device in cancer - Seeking Alpha
seekingalpha.com - January 7 at 7:58 PM |
| Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma - PRNewswire
prnewswire.com - January 7 at 9:57 AM |
| Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma
finance.yahoo.com - January 7 at 9:57 AM |
| Soligenix, Inc. (SNGX) Secures $1.5M NIH Small Business Innovation Research Award to Advance COVID-19 Vaccine Development - StreetInsider.com
streetinsider.com - December 28 at 7:30 AM |
| Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development - PRNewswire
prnewswire.com - December 28 at 7:30 AM |
| Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development
finance.yahoo.com - December 28 at 7:30 AM |
| Mid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares Plummet
benzinga.com - December 24 at 7:32 AM |
| SNGX: Phase 3 Trial of SGX942 Does Not Meet Primary Endpoint…
finance.yahoo.com - December 23 at 10:06 AM |
| Mid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares Plummet - Benzinga
benzinga.com - December 22 at 5:31 PM |
 | BUZZ-U.S. STOCKS ON THE MOVE-Ocugen Inc, Peloton Interactive, Apple - Nasdaq
nasdaq.com - December 22 at 12:29 PM |
| BUZZ-U.S. STOCKS ON THE MOVE-Apple, Ocugen Inc, Soligenix Inc - Nasdaq
nasdaq.com - December 22 at 12:29 PM |
| Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients - Yahoo Finance
finance.yahoo.com - December 22 at 12:29 PM |
| Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
finance.yahoo.com - December 22 at 7:28 AM |
| Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing - PRNewswire
prnewswire.com - December 16 at 9:22 AM |
| Soligenix Announces $20 Million Strategic Convertible Debt Financing Agreement with Pontifax Medison Debt Financing
finance.yahoo.com - December 16 at 9:22 AM |
| Soligenix, Inc. COVID-19 Vaccine Candidate, CiVax, Could Be a More Viable Alternative to Moderna and Pfizer - Yahoo Finance
finance.yahoo.com - December 9 at 9:08 AM |
| Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine - PRNewswire
prnewswire.com - December 9 at 4:06 AM |
| Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine - Yahoo Finance
finance.yahoo.com - December 8 at 6:05 PM |
| Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
prnewswire.com - December 8 at 8:15 AM |
 | SOLIGENIX INC
fool.com - November 27 at 12:28 AM |
| Pfizer and Moderna COVID-19 Vaccine Candidates Are Promising, but Soligenix's Civax (TM) May Be a Better Alternative - Yahoo Finance
finance.yahoo.com - November 17 at 10:30 PM |
